{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:02:23Z","timestamp":1768075343944,"version":"3.49.0"},"reference-count":37,"publisher":"Japanese Society for Dental Materials and Devices","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dental Materials Journal","Dent. Mater. J."],"published-print":{"date-parts":[[2018,7,26]]},"DOI":"10.4012\/dmj.2017-305","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T22:14:23Z","timestamp":1519683263000},"page":"575-581","source":"Crossref","is-referenced-by-count":9,"title":["Surface modification of porous alpha-tricalcium phosphate granules with heparin enhanced their early osteogenic capability in a rat calvarial defect model"],"prefix":"10.4012","volume":"37","author":[{"given":"Yoshihiro","family":"TAKEDA","sequence":"first","affiliation":[{"name":"Department of Oral Implantology, Osaka Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitomo","family":"HONDA","sequence":"additional","affiliation":[{"name":"Institute of Dental Research, Osaka Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiro","family":"KAKINOKI","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"YAMAOKA","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"BABA","sequence":"additional","affiliation":[{"name":"Department of Oral Implantology, Osaka Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2427","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Yamada M, Shiota M, Yamashita Y, Kasugai S. Histological and histomorphometrical comparative study of the degradation and osteoconductive characteristics of alpha- and beta-tricalcium phosphate in block grafts. J Biomed Mater Res B Appl Biomater 2007; 82: 139-148.","DOI":"10.1002\/jbm.b.30715"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Carrodeguas RG, De Aza S. alpha-Tricalcium phosphate: synthesis, properties and biomedical applications. Acta Biomater 2011; 7: 3536-3546.","DOI":"10.1016\/j.actbio.2011.06.019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ishikawa K. Bone substitute fabrication based on dissolution-precipitation reactions. Materials 2010; 3: 1138-1155.","DOI":"10.3390\/ma3021138"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Suzuki O. Octacalcium phosphate (OCP)-based bone substitute materials. Jpn Dent Sci Rev 2013; 49: 58-71.","DOI":"10.1016\/j.jdsr.2013.01.001"},{"key":"5","unstructured":"5) Saska S, Mendes L, Gaspar A, Capote T. In: Turkyilmaz I, editor. Current concepts in dental implantology: InTech; 2015. p. 26-58."},{"key":"6","unstructured":"6) Hirose M, Uemura N, Hashimoto Y, Toda I, Baba S. Bone augmentation of canine frontal sinuses using a porous \u03b1-tricalcium phosphate for implant treatment. J Oral Sci Rehabil 2017; 3: 44-51."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kihara H, Shiota M, Yamashita Y, Kasugai S. Biodegradation process of alpha-TCP particles and new bone formation in a rabbit cranial defect model. J Biomed Mater Res B Appl Biomater 2006; 79: 284-291.","DOI":"10.1002\/jbm.b.30540"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Uchino T, Yamaguchi K, Suzuki I, Kamitakahara M, Otsuka M, Ohtsuki C. Hydroxyapatite formation on porous ceramics of alpha-tricalcium phosphate in a simulated body fluid. J Mater Sci Mater Med 2010; 21: 1921-1926.","DOI":"10.1007\/s10856-010-4042-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, Nemeth EF, Riccardi D. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci U S A 2004; 101: 5140-5145.","DOI":"10.1073\/pnas.0306141101"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Beck G. Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 2003; 288: 288-300.","DOI":"10.1016\/S0014-4827(03)00213-1"},{"key":"11","unstructured":"11) Tokuda T, Honda Y, Hashimoto Y, Matsumoto N. Comparison of the bone forming ability of different sized-alpha tricalcium phosphate granules using a critical size defect model of the mouse calvaria. Nano Biomed 2015; 7: 63-71."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Li P, Hashimoto Y, Honda Y, Arima Y, Matsumoto N. The effect of interferon-gamma and zoledronate treatment on alpha-tricalcium phosphate\/collagen sponge-mediated bone-tissue engineering. Int J Mol Sci 2015; 16: 25678-25690.","DOI":"10.3390\/ijms161025678"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mulloy B, Hogwood J, Gray E, Lever R, Page CP. Pharmacology of heparin and related drugs. Pharmacol Rev 2016; 68: 76-141.","DOI":"10.1124\/pr.115.011247"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nissen NN, Shankar R, Gamelli RL, Singh A, DiPietro LA. Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. Biochem J 1999; 338: 637-642.","DOI":"10.1042\/bj3380637"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Honda Y, Ding X, Mussano F, Wiberg A, Ho CM, Nishimura I. Guiding the osteogenic fate of mouse and human mesenchymal stem cells through feedback system control. Sci Rep 2013; 3: 3420.","DOI":"10.1038\/srep03420"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Olczyk P, Mencner L, Komosinska-Vassev K. Diverse roles of heparan sulfate and heparin in wound repair. Biomed Res Int 2015; 2015: 549417.","DOI":"10.1155\/2015\/549417"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mousavi S, Moradi M, Khorshidahmad T, Motamedi M. Anti-inflammatory effects of heparin and its derivatives: a systematic review. Adv Pharmacol Sci 2015; 2015: 507151.","DOI":"10.1155\/2015\/507151"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Murugesan S, Xie J, Linhardt RJ. Immobilization of heparin: approaches and applications. Curr Top Med Chem 2008; 8: 80-100.","DOI":"10.2174\/156802608783378891"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wu Q, Li Y, Wang Y, Li L, Jiang X, Tang J, Yang H, Zhang J, Bao J, Bu H. The effect of heparinized decellularized scaffolds on angiogenic capability. J Biomed Mater Res A 2016; 104: 3021-3030.","DOI":"10.1002\/jbm.a.35843"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Knaack S, Lode A, Hoyer B, Rosen-Wolff A, Gabrielyan A, Roeder I, Gelinsky M. Heparin modification of a biomimetic bone matrix for controlled release of VEGF. J Biomed Mater Res A 2014; 102: 3500-3511.","DOI":"10.1002\/jbm.a.35020"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kakinoki S, Sakai Y, Fujisato T, Yamaoka T. Accelerated tissue integration into porous materials by immobilizing basic fibroblast growth factor using a biologically safe three-step reaction. J Biomed Mater Res A 2015; 103: 3790-3797.","DOI":"10.1002\/jbm.a.35516"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Vajgel A, Mardas N, Farias BC, Petrie A, Cimoes R, Donos N.A systematic review on the critical size defect model. Clin Oral Implants Res 2014; 25: 879-893.","DOI":"10.1111\/clr.12194"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Honda Y, Anada T, Kamakura S, Morimoto S, Kuriyagawa T, Suzuki O. The effect of microstructure of octacalcium phosphate on the bone regenerative property. Tissue Eng Part A 2009; 15: 1965-1973.","DOI":"10.1089\/ten.tea.2008.0300"},{"key":"24","unstructured":"24) Somasundaram S, Vijayabaskar P. Histological and analytical evaluation of glycosaminoglycan from the clam katelysia opima. Trends Med Res 2007; 2: 165-175."},{"key":"25","unstructured":"25) Galois L, Mainard D. Bone ingrowth into two porous ceramics with different pore sizes: an experimental study. Acta Orthop Belg 2004; 70: 598-603."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hannink G, Arts JJ. Bioresorbability, porosity and mechanical strength of bone substitutes: what is optimal for bone regeneration? Injury 2011; 42 Suppl 2: S22-25.","DOI":"10.1016\/j.injury.2011.06.008"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Bigi A, Boanini E, Botter R, Panzavolta S, Rubini K. Alpha-tricalcium phosphate hydrolysis to octacalcium phosphate: effect of sodium polyacrylate. Biomaterials 2002; 23: 1849-1854.","DOI":"10.1016\/S0142-9612(01)00311-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Bhandari M, Hirsh J, Weitz J, Young E, Venner T, Shaughnessy S. The effects of standard and low molecular weight heparin on bone nodule formation in vitro. Thromb Haemost 1998; 80: 413-417.","DOI":"10.1055\/s-0037-1615222"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kanzaki S, Takahashi T, Kanno T, Ariyoshi W, Shinmyouzu K, Tujisawa T, Nishihara T. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. J Cell Physiol 2008; 216: 844-850.","DOI":"10.1002\/jcp.21468"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Hausser HJ, Brenner RE. Low doses and high doses of heparin have different effects on osteoblast-like Saos-2 cells in vitro. J Cell Biochem 2004; 91: 1062-1073.","DOI":"10.1002\/jcb.20007"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Miyazaki T, Miyauchi S, Tawada A, Anada T, Matsuzaka S, Suzuki O. Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation. J Cell Physiol 2008; 217: 769-777.","DOI":"10.1002\/jcp.21557"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kobayashi N, Hashimoto Y, Otaka A, Yamaoka T, Morita S. Porous alpha-tricalcium phosphate with immobilized basic fibroblast growth factor enhances bone regeneration in a canine mandibular bone defect model. Materials 2016; 9: 853.","DOI":"10.3390\/ma9100853"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Noborn F, O\u2019Callaghan P, Hermansson E, Zhang X, Ancsin JB, Damas AM, Dacklin I, Presto J, Johansson J, Saraiva MJ, Lundgren E, Kisilevsky R, Westermark P, Li JP. Heparan sulfate\/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein. Proc Natl Acad Sci U S A 2011; 108: 5584-5589.","DOI":"10.1073\/pnas.1101194108"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Cowman M, Slahetka M, Hittner D, Kim J, Forino M, Gadelrab G.Polyacrylamide-gel electrophoresis and Alcian Blue staining of sulphated glycosaminoglycan oligosaccharides. Biochem J 1984; 221: 707-716.","DOI":"10.1042\/bj2210707"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kuo WJ, Digman MA, Lander AD. Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization. Mol Biol Cell 2010; 21: 4028-4041.","DOI":"10.1091\/mbc.e10-04-0348"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Khan SA, Nelson MS, Pan C, Gaffney PM, Gupta P. Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity. Am J Physiol Cell Physiol 2008; 294: C1387-1397.","DOI":"10.1152\/ajpcell.00346.2007"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Bramono DS, Murali S, Rai B, Ling L, Poh WT, Lim ZX, Stein GS, Nurcombe V, van Wijnen AJ, Cool SM. Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone 2012; 50: 954-964.","DOI":"10.1016\/j.bone.2011.12.013"}],"container-title":["Dental Materials Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/dmj\/37\/4\/37_2017-305\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T05:00:50Z","timestamp":1533358850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/dmj\/37\/4\/37_2017-305\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4012\/dmj.2017-305","relation":{},"ISSN":["0287-4547","1881-1361"],"issn-type":[{"value":"0287-4547","type":"print"},{"value":"1881-1361","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]}}}